1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Copernicus Capital Management, LLC Buys Bristol-Myers Squibb Company, UnitedHealth Group Inc, IQVIA Holdings Inc, Sells Merck Inc, Intuitive Surgical Inc, Illumina Inc

Investment company Copernicus Capital Management, LLC buys Bristol-Myers Squibb Company, UnitedHealth Group Inc, IQVIA Holdings Inc, Horizon Therapeutics PLC, Heron Therapeutics Inc, Nevro Corp, sells Merck Inc, Intuitive Surgical Inc, Illumina Inc, CVS Health Corp, Gilead Sciences Inc, WellCare Health Plans Inc, Vertex Pharmaceuticals Inc, Allergan PLC, Stryker Corp during the 3-months ended 2019Q1, according to the most recent filings of the investment company, Copernicus Capital Management, LLC. As of 2019Q1, Copernicus Capital Management, LLC owns 14 stocks with a total value of $39 million. These are the details of the buys and sells.

For the details of Copernicus Capital Management, LLC's stock buys and sells, go to https://www.gurufocus.com/guru/copernicus+capital+management%2C+llc/current-portfolio/portfolio

These are the top 5 holdings of Copernicus Capital Management, LLC
  1. Thermo Fisher Scientific Inc (TMO) - 18,990 shares, 13.33% of the total portfolio. Shares reduced by 0.05%
  2. Zoetis Inc (ZTS) - 50,413 shares, 13.01% of the total portfolio. Shares added by 10.95%
  3. Bristol-Myers Squibb Company (BMY) - 85,000 shares, 10.40% of the total portfolio. New Position
  4. Heron Therapeutics Inc (HRTX) - 135,946 shares, 8.52% of the total portfolio. Shares added by 46.18%
  5. Vertex Pharmaceuticals Inc (VRTX) - 17,863 shares, 8.43% of the total portfolio. Shares reduced by 45.68%
New Purchase: Bristol-Myers Squibb Company (BMY)

Copernicus Capital Management, LLC initiated holding in Bristol-Myers Squibb Company. The purchase prices were between $45.12 and $53.8, with an estimated average price of $49.88. The stock is now traded at around $46.63. The impact to a portfolio due to this purchase was 10.4%. The holding were 85,000 shares as of .

New Purchase: UnitedHealth Group Inc (UNH)

Copernicus Capital Management, LLC initiated holding in UnitedHealth Group Inc. The purchase prices were between $236.02 and $271.13, with an estimated average price of $255.35. The stock is now traded at around $236.08. The impact to a portfolio due to this purchase was 7.61%. The holding were 12,000 shares as of .

New Purchase: IQVIA Holdings Inc (IQV)

Copernicus Capital Management, LLC initiated holding in IQVIA Holdings Inc. The purchase prices were between $109.96 and $144.45, with an estimated average price of $133.07. The stock is now traded at around $135.27. The impact to a portfolio due to this purchase was 7.38%. The holding were 20,000 shares as of .

New Purchase: Horizon Therapeutics PLC (HPR)

Copernicus Capital Management, LLC initiated holding in Horizon Therapeutics PLC. The purchase prices were between $16.5 and $25.2, with an estimated average price of $20.53. The stock is now traded at around $23.60. The impact to a portfolio due to this purchase was 4.47%. The holding were 66,000 shares as of .

New Purchase: Nevro Corp (NVRO)

Copernicus Capital Management, LLC initiated holding in Nevro Corp. The purchase prices were between $35.52 and $62.62, with an estimated average price of $46.85. The stock is now traded at around $62.26. The impact to a portfolio due to this purchase was 0.8%. The holding were 5,000 shares as of .

Added: Heron Therapeutics Inc (HRTX)

Copernicus Capital Management, LLC added to a holding in Heron Therapeutics Inc by 46.18%. The purchase prices were between $23.15 and $28.34, with an estimated average price of $26.21. The stock is now traded at around $18.13. The impact to a portfolio due to this purchase was 2.69%. The holding were 135,946 shares as of .

Sold Out: Merck & Co Inc (MRK)

Copernicus Capital Management, LLC sold out a holding in Merck & Co Inc. The sale prices were between $72.92 and $83.17, with an estimated average price of $78.33.

Sold Out: CVS Health Corp (CVS)

Copernicus Capital Management, LLC sold out a holding in CVS Health Corp. The sale prices were between $52.36 and $69.88, with an estimated average price of $61.96.

Sold Out: WellCare Health Plans Inc (WCG)

Copernicus Capital Management, LLC sold out a holding in WellCare Health Plans Inc. The sale prices were between $230.61 and $282.5, with an estimated average price of $258.4.

Sold Out: Allergan PLC (AGN)

Copernicus Capital Management, LLC sold out a holding in Allergan PLC. The sale prices were between $132.09 and $160.79, with an estimated average price of $144.95.



Here is the complete portfolio of Copernicus Capital Management, LLC. Also check out:

1. Copernicus Capital Management, LLC's Undervalued Stocks
2. Copernicus Capital Management, LLC's Top Growth Companies, and
3. Copernicus Capital Management, LLC's High Yield stocks
4. Stocks that Copernicus Capital Management, LLC keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:


Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)